Virucidal effect of mouthwash on acyclovir-resistant herpes simplex virus

M Bar Ilan1,2, S Dovrat3, R Cohen3

  • 1Oral Medicine Unit, Sheba Medical Center, Tel-Hashomer, Israel.

Oral Diseases
|December 27, 2023
PubMed
Abstract

Insights

Commercially available mouthwashes show antiviral activity against acyclovir-resistant herpes simplex virus type 1 (HSV-1) in vitro. Essential oil and povidone-iodine mouthwashes were most effective, suggesting potential for managing HSV-1 infections in immunocompromised patients.

Area of Science:

  • Virology
  • Oral Medicine
  • Infectious Diseases

Background:

  • Herpes simplex virus type 1 (HSV-1) infections can be severe in immunocompromised individuals.
  • Acyclovir (ACV)-resistant HSV-1 strains frequently emerge due to long-term antiviral therapy.
  • Managing these resistant strains presents a clinical challenge.

Purpose of the Study:

  • To evaluate the virucidal efficacy of common mouthwashes against acyclovir-resistant HSV-1 strains.
  • To compare the effectiveness of different mouthwash formulations.

Main Methods:

  • Two acyclovir-resistant HSV-1 strains were tested.
  • Exposure to essential oil-based, chlorhexidine gluconate, and povidone-iodine mouthwashes for 30 seconds.
  • Virus infectivity assessed using plaque reduction assays.

Main Results:

  • All tested mouthwashes significantly reduced HSV-1 infectivity in vitro.
  • Essential oil-based and povidone-iodine mouthwashes demonstrated slightly greater efficacy than chlorhexidine.
  • The tested oral rinses exhibited in vitro antiviral activity against ACV-resistant HSV.

Conclusions:

  • Commercially available mouthwashes possess in vitro antiviral properties against acyclovir-resistant HSV.
  • Further clinical trials are necessary to confirm the effectiveness of these rinses in reducing oral HSV lesions in immunocompromised patients.